Cross adsorbed goat anti human igg h l secondary antibody

Manufactured by Thermo Fisher Scientific

The cross-adsorbed goat anti-human IgG (H+L) secondary antibody is a reagent used in immunological assays. It binds to the heavy and light chains of human immunoglobulin G (IgG) antibodies. The antibody is cross-adsorbed to remove non-specific reactivity.

Automatically generated - may contain errors

Lab products found in correlation

Ds 626 g, by LGC (2 mentions) Ds 626 n, by LGC (2 mentions)

Close spelling variants of this product

Goat anti-human IgG [H+L] Cross-Adsorbed Secondary HRP-Antibody Alexa Fluor™ 647 Goat anti-Human IgG (H+L) Cross-Adsorbed Secondary Antibody Goat anti-human IgG cross-adsorbed secondary Goat anti-human IgG (H + L) secondary antibody H + L IgG

2 protocols using cross adsorbed goat anti human igg h l secondary antibody

Convalescent Plasma Antibody Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols

IBC Protocol 20004 approved the use of SARS-CoV-2 convalescent plasma. Anonymized plasma samples of SARS-CoV-2 convalescent individuals (N=19) were obtained from UCSD. Individuals were confirmed to be infected in the previous three to ten weeks by PCR and lateral flow assay. All individuals were symptomatic with mild to moderate-severe symptoms. Serum samples (DS-626-G and DS-626-N, Seracare) purchased before SARS-CoV-2 pandemic were used as a negative control. SARS-CoV-2-specific binding antibodies in plasma samples were measured as described above. Cross-adsorbed goat anti-human IgG (H+L) secondary antibody (A18811, Invitrogen) was used at a dilution of 1:3,000.

Chiuppesi F., Salazar M.D., Contreras H., Nguyen V.H., Martinez J., Park S., Nguyen J., Kha M., Iniguez A., Zhou Q., Kaltcheva T., Levytskyy R., Ebelt N.D., Kang T.H., Wu X., Rogers T., Manuel E.R., Shostak Y., Diamond D.J, & Wussow F. (2020). Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine. bioRxiv.

+ Open protocol

+ Expand

SARS-CoV-2 Convalescent Plasma Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

IBC Protocol 20004 approved the use of SARS-CoV-2 convalescent plasma. Anonymized plasma samples of SARS-CoV-2 convalescent individuals (N = 19) were obtained from UCSD. Individuals were confirmed to be infected in the previous three to ten weeks by PCR and lateral flow assay. All individuals were symptomatic with mild to moderate-severe symptoms. Serum samples (DS-626-G and DS-626-N, Seracare) purchased before SARS-CoV-2 pandemic were used as a negative control. SARS-CoV-2-specific binding antibodies in plasma samples were measured as described above. Cross-adsorbed goat anti-human IgG (H + L) secondary antibody (A18811, Invitrogen) was used at a dilution of 1:3,000.

Chiuppesi F., Salazar M.D., Contreras H., Nguyen V., Martinez J., Park S., Nguyen J., Kha M., Iniguez A., Zhou Q., Kaltcheva T., Levytskyy R., Ebelt N., Kang T., Wu X., Rogers T., Manuel E., Shostak Y., Diamond D, & Wussow F. (2020). Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform. Research Square.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!